Chung‐Yu Chen
- Rehabilitation top 5%
- Exercise and Physiological Responses 7
-
- Lung Cancer Treatments and Mutations 18
- Lung Cancer Diagnosis and Treatment 9
- Pleural and Pulmonary Diseases 6
- Orthopedics and Sports Medicine top 10%
-
- Lung Cancer Research Studies 8
-
- Tuberculosis Research and Epidemiology 9
-
- Muscle metabolism and nutrition 6
-
- Mycobacterium research and diagnosis 6
- Co-authors
- Chong‐Jen YuJin‐Yuan ShihChao‐Chi HoPan‐Chyr YangJou‐Wei LinKuan‐Yu ChenShin‐Da LeeChia‐Hua Kuo
- Journals
- SHILAP Revista de lepidopterología (1 paper)ACS Nano (1 paper)PLoS ONE (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Chung‐Yu Chen
83 papers receiving 962 citations
Peers
Comparison fields: 5 of 124
- Rehabilitation 91
- Pulmonary and Respiratory Medicine 290
- Complementary and alternative medicine 64
- Orthopedics and Sports Medicine 56
- Oncology 168
Countries citing papers authored by Chung‐Yu Chen
This map shows the geographic impact of Chung‐Yu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Yu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Yu Chen more than expected).
Fields of papers citing papers by Chung‐Yu Chen
This network shows the impact of papers produced by Chung‐Yu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Yu Chen. The network helps show where Chung‐Yu Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chung‐Yu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 25 | |
| 6 | 2023 | 6 | |
| 7 | T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study) | 2023 | 3 |
| 8 | 2022 | 13 | |
| 9 | 2020 | 0 | |
| 10 | 2019 | 16 | |
| 11 | Real-World Crizotinib Use for Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer under First-Year National Health Insurance Coverage in Taiwan | 2018 | 1 |
| 12 | 2016 | 10 | |
| 13 | 2014 | 11 | |
| 14 | 2013 | 3 | |
| 15 | 2013 | 19 | |
| 16 | 2012 | 12 | |
| 17 | 2011 | 2 | |
| 18 | 2010 | 22 | |
| 19 | 2006 | 9 | |
| 20 | THE BIOMECHANICAL ANALYSIS OF STRAIGHT AND FLEXURAL LEG SWING OF THE CHINESE MARTIAL ARTS JUMPING FRONT KICK | 1998 | 2 |
About Chung‐Yu Chen
Chung‐Yu Chen is a scholar working on Microbiology, Rehabilitation and Pulmonary and Respiratory Medicine, having authored 88 papers that have together received 976 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Tuberculosis Research and Epidemiology (9 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Research Studies (8 papers), Exercise and Physiological Responses (7 papers), Muscle metabolism and nutrition (6 papers), Mycobacterium research and diagnosis (6 papers) and Pleural and Pulmonary Diseases (6 papers). The work is most often cited by research in Rehabilitation (91 citations), Pulmonary and Respiratory Medicine (290 citations) and Complementary and alternative medicine (64 citations). Chung‐Yu Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chong‐Jen Yu, Jin‐Yuan Shih, Chao‐Chi Ho, Pan‐Chyr Yang, Jou‐Wei Lin, Kuan‐Yu Chen, Shin‐Da Lee, Chia‐Hua Kuo, Chun‐Ta Huang and Chien‐Wen Hou. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.